DIADEMA PARTNERS LP Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$580.5M

Holdings

119

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (119 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	PRQRPROQR THRAPEUTICS N V	167,532	$338K	0.06%
102	HRMYHARMONY BIOSCIENCES HLDGS IN	7,500	$280K	0.05%
103	AARDAARDVARK THERAPEUTICS INC	15,882	$208K	0.04%
104	PBYIPUMA BIOTECHNOLOGY INC	33,800	$201K	0.03%	Call
105	NEUPNEUPHORIA THERAPEUTICS INC	50,000	$194K	0.03%
106	PLRXPLIANT THERAPEUTICS INC	144,914	$176K	0.03%
107	ONCBEONE MEDICINES LTD	7,500	$172K	0.03%
108	FHTXFOGHORN THERAPEUTICS INC	30,630	$165K	0.03%
109	TLPHTALPHERA INC	136,923	$156K	0.03%
110	—REVIVA PHARMACEUTCLS HLDGS I	500,000	$139K	0.02%	Call
111	VTGNVISTAGEN THERAPEUTICS INC	206,500	$136K	0.02%	Call
112	PRTCPURETECH HEALTH PLC	7,442	$123K	0.02%
113	LYELLYELL IMMUNOPHARMA INC	3,800	$116K	0.02%	Put
114	INBXINHIBRX BIOSCIENCES INC	1,299	$102K	0.02%
115	EDSAEDESA BIOTECH INC	54,025	$76K	0.01%
116	ATYRATYR PHARMA INC	27,300	$21K	0.00%	Put
117	SAVACASSAVA SCIENCES INC	10,600	$20K	0.00%	Put
118	JBIOJADE BIOSCIENCES INC	1,046	$2K	0.00%	Put
119	APLTAPPLIED THERAPEUTICS INC	20,200	$2K	0.00%	Call

PreviousPage 2 of 2